Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Novartis AG
  6. News
  7. Most relevant
    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about NOVARTIS AG
06:41aBioNTech Plans 50% Workforce Boost, $57 Million Investment At German Factory
MT
01/25Merus Regains Worldwide Rights to MCLA-145 After Incyte Opt-Out; Names Chief Commercial..
MT
01/25NOVARTIS AG : Goldman Sachs gives a Buy rating
MD
01/25AlphaValue/Baader Europe Lowers Price Target on Novartis, Upgrades Recommendation to Bu..
MT
01/24NOVARTIS : 2021 Global Managed Access Program Community Update
PU
01/20BAUSCH HEALTH BRIEF : He Will join Bausch + Lomb from Allergan/AbbVie; Prior to that, he w..
MT
01/20NOVARTIS AG : JP Morgan keeps a Sell rating
MD
01/20"SHOW MORE OF YOU" : Amgen V. Sandoz, Battling It Out On Amgen's Otezla« Drug
AQ
01/18Novartis CEO Expects Worldwide Normalcy to COVID-19 By 2022-End
MT
01/18GLOBAL MARKETS LIVE : Toyota, Microsoft, Goldman Sachs, Alibaba, Boeing...
01/18Molecular Partners Shares Drop 14% After Novartis Deal
DJ
01/18Wall Street Set for Downbeat Open Amid Rising Treasury Yields
MT
01/18Health Care Stocks Retreat Pre-Bell Tuesday
MT
01/18Top Premarket Decliners
MT
01/18Medicenna Therapeutics up 12.7% in US Trade, Details Management Change, Appoints Develo..
MT
01/18Molecular Partners to License Ensovibep to Novartis for COVID-19
MT
01/18Molecular Partners, Novartis Enter Definitive License Deal For COVID-19 Therapy
MT
01/15Factbox-GSK's consumer health business
RE
01/14NOVARTIS AG : Morgan Stanley gives a Neutral rating
MD
01/12Novartis to File for COVID-19 Drug's Emergency Use in US by February Amid Omicron Surge
MT
01/12NOVARTIS AG : JP Morgan reiterates its Sell rating
MD
01/11Novartis Mulls Oncology, Cardiovascular Treatment Expansion
MT
01/10GLOBAL MARKETS LIVE : Meta, Goldman Sachs, Novartis, Tesla, Boeing...
01/10Novartis-Molecular Partners COVID drug could be approved in weeks
RE
01/10Molecular Partners Shares Rise 19% After Ensovibep Trial Meets Primary Endpoint
DJ
01/10Novartis Still Undecided On Future Of Sandoz
MT
01/10Novartis CEO says no decision has been taken on Sandoz
RE
01/10Molecular Partners Shares Rise 37% Premarket After Trial Meets Primary Endpoint
DJ
01/10EUROPEAN MIDDAY BRIEFING - Stocks Edge Lower, -2-
DJ
01/10MARKETSCREENER’S WORLD PRESS REVIEW : January 10, 2022
01/10Novartis, Molecular Partners Move Forward with COVID-19 Drug After Phase 2 Trial Succes..
MT
01/10Molecular Partners Says Mid-Stage Study of Potential COVID-19 Treatment Meets Primary E..
MT
01/10NOVARTIS : COVID-19 news feed
PU
01/10Novartis in-licenses COVID-19 treatment ensovibep from Molecular Partners
RE
01/10Novartis, Molecular Partners Report Positive Data for Covid-19 Treatment Ensovibep
DJ
01/10Novartis, Molecular Partners' COVID-19 Treatment Reduces Viral Load in Mid-Stage Trial
MT
01/10Novartis in-licenses COVID-19 treatment ensovibep from Molecular Partners
RE
01/10Novartis and Molecular Partners Report Positive Topline Data from Phase 2 Study for ens..
CI
01/07NOVARTIS AG : UBS reiterates its Neutral rating
MD
01/06Novartis, Alnylam Collaborate on Liver-Targeted Therapy
MT
01/06NOVARTIS : announces collaboration with Alnylam to explore targeted therapy to restore liv..
PU
01/06Novartis, Alnylam Pharmaceuticals Partner to Develop Liver-Targeted Therapy
MT
01/05Novartis announces U.S. Court of Appeals for the Federal Circuit (CAFC) upholds validit..
AQ
01/04ADRs Close Mostly Higher; Toyota Trades Actively
DJ
01/04EUROPEAN MIDDAY BRIEFING - Stocks Gain as -2-
DJ
01/04Novartis Says US Appeals Court Upholds Gilenya Dosing Patent
MT
01/04NOVARTIS AG : JP Morgan reiterates its Sell rating
MD
01/04Novartis Wins US Court Appeal After Challenge to Gilenya Patent
DJ
01/04NOVARTIS : announces U.S. Court of Appeals for the Federal Circuit (CAFC) upholds validity..
PU
01/04Novartis announces U.S. Court of Appeals for the Federal Circuit (CAFC) upholds validit..
DJ
01/03Novartis Lands Favorable Ruling From US Court Over Multiple Sclerosis Drug Patent
MT
2021The Federal Court Interprets Patent Agent Privilege Provision Of The Patent Act
AQ
2021Wolfe Research Lowers Price Target on Novartis, Maintains Outperform Recommendation
MT
2021Tech, healthcare stocks lead European shares lower as Omicron cases swell
RE
2021UK Clears Novartis' Piqray Drug for Men With Breast Cancer
MT
2021Novartis Cosentyx receives FDA approval for the treatment of children and adolescents w..
AQ
2021Sandoz launches authorized generic of Narcan (naloxone hydrochloride) Nasal Spray 4 mg ..
AQ
2021NOVARTIS AG : Receives a Buy rating from Jefferies
MD
2021NOVARTIS AG : Buy rating from Goldman Sachs
MD
2021GLOBAL MARKETS LIVE : Pfizer, Tesla, JD.com, Warner, Cintas...
2021Novartis' Cosentyx Wins US Approval for Use in Children With Certain Types of Arthritis
MT
2021Novartis Says FDA Approved Cholesterol Therapy
DJ
2021Novartis Wins US FDA Nod For Arthritis Treatment in Children, Adolescents
MT
2021Novartis' Bad Cholesterol Reduction Drug Leqvio Gets US FDA Approval
MT
2021Novartis Says FDA Approves Cosentyx to Treat Some Children, Adolescents With Arthritis
DJ
2021Novartis Cosentyx(R) receives FDA approval for the treatment of children and adolescent..
DJ
2021Novartis Cosentyx« Receives FDA Approval for the Treatment of Children and Adolescents ..
CI
2021Novartis Wins US FDA Approval for Leqvio Cholesterol-Reduction Therapy
MT
2021Health Care Up As Omicron Seen Spurring Demand For Vaccines, Medications -- Health Care..
DJ
2021FDA Approves Novartis Leqvio, First-In-Class Sirna to Lower Cholesterol and Keep It Low..
CI
2021FDA approves Novartis Leqvio(R) (inclisiran), first-in-class siRNA to lower cholesterol..
DJ
2021FTSE 100 Ends Wednesday Up as UK Traders Appear Cautiously Optimistic
DJ
2021ETF PREVIEW : ETFs Mostly Flat, Futures Inch Higher as Wall Street Digests Measures Vs Omi..
MT
2021Omicron Weighs on Already Struggling U.K. Economy
DJ
2021EUROPEAN MIDDAY BRIEFING - Shares Little Changed, Appetite Remains Fragile
DJ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on NOVARTIS AG